Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong – 5 February 2018
Stephen R. Atkinson, Andrew McQuillin, Marsha Y. Morgan, Mark R. Thursz – 2 February 2018
Ann‐Sofie Vercouter, Philip Meuleman – 2 February 2018
2 February 2018
Paula Olaizola, Maria J. Perugorria, Jesus M. Banales – 2 February 2018
Gyongyi Szabo, Emma Brink – 2 February 2018
Cuiqin Zhang, Fuyong Song – 2 February 2018
Helit Cohen, Hila Barash, Irit Meivar‐Levy, Kfir Molakandov, Marina Ben‐Shimon, Michael Gurevich, Fatima Zoabi, Adi Har‐Zahav, Rolf Gebhardt, Frank Gaunitz, Michael Gurevich, Eytan Mor, Philippe Ravassard, Shoshana Greenberger, Sarah Ferber – 2 February 2018 – Transdifferentiation (TD) is the direct reprogramming of adult cells into cells of alternate fate and function. We have previously shown that liver cells can be transdifferentiated into beta‐like, insulin‐producing cells through ectopic expression of pancreatic transcription factors (pTFs).
Qiang Liu, Laura Buccini, Daniele Pezzati, Ahmed Hassan, Teresa Diago Uso, Charles Miller, Cristiano Quintini – 1 February 2018
Kenichiro Kobayashi, Takako Yoshioka, Jun Miyauchi, Atsuko Nakazawa, Nobutaka Kiyokawa, Toshiro Maihara, Ikuya Usami – 1 February 2018 – Liver fibrosis is a common complication associated with transient myeloproliferative disorder (TMD) in Down syndrome (DS). The exact molecular pathogenesis that regulates disease progression is largely unknown. We recently found serum and/or urinary monocyte chemoattractant protein‐1 (MCP‐1) as a novel biomarker of liver fibrosis.